Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Prepaid Assets: 2018-2025

Historic Prepaid Assets for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to $85.3 million.

  • Autolus Therapeutics' Prepaid Assets rose 43.24% to $85.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.3 million, marking a year-over-year increase of 43.24%. This contributed to the annual value of $67.3 million for FY2024, which is 92.55% up from last year.
  • As of Q3 2025, Autolus Therapeutics' Prepaid Assets stood at $85.3 million, which was up 25.73% from $67.9 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Prepaid Assets registered a high of $85.3 million during Q3 2025, and its lowest value of -$22.7 million during Q3 2021.
  • In the last 3 years, Autolus Therapeutics' Prepaid Assets had a median value of $51.6 million in 2024 and averaged $57.3 million.
  • Per our database at Business Quant, Autolus Therapeutics' Prepaid Assets slumped by 118.90% in 2021 and then skyrocketed by 682.62% in 2022.
  • Over the past 5 years, Autolus Therapeutics' Prepaid Assets (Quarterly) stood at $36.3 million in 2021, then climbed by 18.56% to $43.0 million in 2022, then decreased by 18.70% to $35.0 million in 2023, then soared by 92.55% to $67.3 million in 2024, then skyrocketed by 43.24% to $85.3 million in 2025.
  • Its last three reported values are $85.3 million in Q3 2025, $67.9 million for Q2 2025, and $68.8 million during Q1 2025.